Podcasts about Proton therapy

In this episode, we're joined by Dr. Daniel Indelicato and Dr. Rohan Deraniyagala, two distinguished experts whose work is transforming the landscape of pediatric oncology. With decades of combined experience and groundbreaking research, Danny and Rohan offer invaluable insights into the world of proton therapy. Listen as they unpack the distinct advantages of proton therapy, shedding light on why this method is especially beneficial for children by minimizing harmful side effects and enhancing quality of life post-treatment.The views expressed in this podcast are those of the interviewees. By listening to this, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating.  Consult your own physician for any medical issues that you may be having.  This entire disclaimer also applies to any guests or contributors to the podcast.  Under no circumstances shall Ion Beam Applications SA (IBA), any guests or contributors to the podcast, or any employees, associates, or affiliates of IBA be responsible for damages arising from use of the podcast.

We celebrate a milestone for the first-ever proton therapy center in Kansas City. 500 patients and counting have received this innovative cancer care. Meet the young and old patients who received this beam of hope.

Matthew Pantelis speaks with Treasurer Stephen Mullighan on the Bragg Centre for Proton therapy. Listen live on the FIVEAA Player. Follow us on Facebook, X and Instagram.See omnystudio.com/listener for privacy information.

Check out the latest QuadCast where we interview Jason Efstathiou at the 2024 ASTRO Annual Meeting about his Plenary Session on the PARTIQoL trial, which is a first of its kind randomized trial of IMRT vs. Proton Therapy for localized prostate cancer. Don't miss it. @QuadShotNews@drjefstathiou@HarvardRadOnc@SamuelMarcromMD Check out the website and subscribe to the newsletter! www.quadshotnews.com Founders & Lead Authors: Laura Dover & Caleb Dulaney Podcast Host: Sam Marcrom

Research shows that over the past 20 years, there has been an alarming increase of breast cancer in women younger than 50, which means now, more than ever, it's so important to get screened – no matter your age! Host: Johanna Gomez Guests: Starr Mautner, M.D., Breast Surgical Oncologist at Baptist Health Miami Cancer Institute Stephanie Rico Masterson, Breast Cancer Survivor

Approaching cancer from unique angles and perspectives is crucial for gaining an understanding of this disease and optimizing treatment strategies for patients. In the Department of Radiation Oncology at The University of Kansas Cancer Center, our specialists work to accelerate progress toward more personalized and effective ways to treat cancer through research and clinical trials. In this episode of the Bench to Bedside podcast, Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, speaks with Dr. Xinglei Shen, associate professor in the Department of Radiation Oncology at the cancer center. Dr. Shen directs clinical research efforts in the Department of Radiation Oncology and in this episode, he highlights the significant technological advancements in radiation therapy over the past decade, including innovations like proton beam therapy and precision medicine. Dr. Shen also explains the diverse types of cancer research conducted at KU, the importance of patient advocacy in clinical trials, and his vision for the future of radiation oncology. Links from this Episode: Learn more about Proton Therapy at KU Cancer Center Dr. Xinglei Shen discusses the latest clinical trials and importance of patient-centered research on the KU Cancer Center blog Learn about the Department of Radiation Oncology at KU Cancer Center Follow the Department of Radiation Oncology on X (formerly Twitter) and Instagram

Sue Yom, our Editor in Chief, hosts a discussion of two related articles, Temporal Evolution and Diagnostic Diversification of Patients Receiving Proton Therapy in the United States: A Ten-Year Trend Analysis (2012-21) from the National Association for Proton Therapy and Improving Access to Proton Therapy in the United States and Around the World, from the July 15, 2024 issue. Guests are first authors Dr. William Hartsell, former Medical Director of the Northwestern Medicine Proton Center, now practicing in the Advocate and Alexian systems in the Chicago area, and Dr. Derek Tsang, Associate Professor at the University of Toronto and Clinician Investigator in the Radiation Medicine Program at Princess Margaret Cancer Centre.

This segment of “Cancer Registry World” features Dr. Roshan Prabhu, MD, the Director of the Proton Therapy Center at the Atrium Health - Levine Cancer Institute in Charlotte, NC. Dr. Prabhu discusses the application and importance of collecting registry information for patients treated with the relatively new radiation oncology technique of proton therapy. Please enjoy listening and learning!

Wellness Rising from the Wellness House of Annapolis welcomes Dr. Carol Tweed of Maryland Oncology Hematology & Dr. Liz Nichols from Maryland Proton Treatment Center. They discuss working together to bring the best coordinated personal care with systemic & radiation treatments to fight cancer.

In a conversation with CancerNetwork® at John Theurer Cancer Center, Timothy Chen, MD, highlighted various novel treatment strategies that have impacted his care of patients with brain tumors and other types of cancer.  Chen, a board-certified radiation oncologist and medical director of the Central Nervous System Program at Jersey Shore University Medical Center and the director of Proton Therapy in the Department of Radiation Oncology at Hackensack Meridian Health, first discussed his use of the novel stereotactic radiosurgery modality ZAP-X for patients with brain tumors. According to Chen, this tool may allow for practices to administer radiation at submillimeter precision, which can spare normal tissue from receiving excess radiation. Another technology that Chen highlighted included GammaTile, a radiation treatment that was developed for the management of brain tumors. He said that this collagen tile may help with administering strong radiation to precisely where the tumor is located, while also protecting healthy tissues to minimize the adverse effects from radiation therapy. Specifically, Chen stated that GammaTile may be beneficial for those with larger, difficult-to-treat tumors. Finally, Chen discussed the potential applications of proton therapy and how it may improve outcomes in patients compared with standard radiotherapy. According to Chen, proton therapy serves a “great purpose” with what he described as a precise depth charge that can minimize toxicity during treatment.  Additionally, Chen described how proton therapy may help reduce the probability of developing mutations or secondary cancers among pediatric patients. He highlighted the potential benefit of this modality based on a specific case in which a pediatric patient with myxopapillary ependymoma experienced improvements in pain and urinary control following proton therapy. Regarding these novel forms of therapy, Chen emphasized the notion of multidisciplinary care and said that practices should “work together as a team” when operating these technologies. “[With] all this technology, it's not just used as it is; the technology brings us to work together,” Chen said. “I think multidisciplinary care is the future. People are no longer siloed…. We all work together.” 

Samantha Rux from OSF Healthcare joined Wake Up Tri-Counties to talk about the first patient to undergo Proton Therapy at the OSF Cancer Institute in Peoria. The first patient was a man from Princeton who traveled to Peoria to undergo this extraordinary new treatment that more directly attacks cancer cells with proton therapy as a opposed to traditional radiation which can't specifically target cancer cells. This innovation can't treat all cancers but it is proving to be innovative and effective on most types of cancer. Samantha Rux talked about Proton Therapy on Wake Up Tri-Counties. 

A new paper in the Journal of Clinical Oncology is reporting that the bowel and urinary side-effects of proton therapy (a high tech and very expensive type of radiotherapy), are no better than side-effects after standard high-quality radiotherapy (called IMRT). Quite a fuss on twitter when this paper came on line last week including from a fair few urologists, one of whom described proton therapy for prostate cancer as "a black eye for American healthcare"! (Thanks Scott!). We chat with lead author Dr James Yu (Hartford, USA), and favourite GU Cast radiation oncologist Prof Shankar Siva to make sense of it all. And what does this mean for proton therapy in places like Australia who currently have no proton therapy facility.Even better on our YouTube channel  Links: JCO paper 

Dr. Selim Firat, an Oncologist at Children

Andy Buffler is Professor at The Physics Department at The University of CapeTown and Director of the' MeASURe' Metrological and Applied SciencesUniversity Research Unit and he joins John as one of the pioneers of aninnovative design and business case for a proton therapy center to aid cancerpatients in Cape Town.See omnystudio.com/listener for privacy information.

Dr Timothy Cripe, Dr Joshua Palmer, and Kayla Young visit the studio as we explore proton therapy as a treatment for pediatric cancer. Discover how this technology delivers precise radiation with fewer side effects. We hope you can join us!

Dr. Matthew Ferris, Associate Professor of Radiation Oncology at the University of Maryland Medical school is our guest. Dr. Ferris talks about Proton Therapy, which treats many cancers with a stream of protons in a controllable dose that limits radiation exposure to surrounding parts of the body, and as a result lowers the overall damage and improves future outcomes. 

Wellness Rising from the Wellness House of Annapolis welcomes Dr. Sarah McAvoy, Associate Professor of Radiation Oncology at the University of Maryland School of Medicine. She talks about how the use of Proton Radiation Therapy allows a more targeted treatment of a section of cancerous tissue, which reduces the risk of radiation damage to the surrounding tissue and organs.

On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker continue The Insider's Guide to Radiation Therapy! Here are the figures/graphics we referenced during the show:The first figure we discussed, demonstrating the Bragg Peak and the difference between proton and photon (x-ray) beams. The second figure we discussed, comparing 3D photon (x-ray) radiation, intensity modulated radiotherapy with photons (x-ray), passive scatter and intensity modulated proton therapy.Here are some other things we discussed during the show:Relative biological effectiveness in radiobiologyA video about "IMRT for proton therapy", or pencil beam scanning proton therapy, from manufacturer IBA.Brada review of proton evidence, questioning whether the US should open so many proton centers so quickly. Goitein and Cox response to Brada, arguing that the benefit of proton therapy is self-evident.Glatstein, Glick, Kaiser, and Hahn, arguing that trials are needed to prove the benefit of proton therapy.Liao et al., randomized phase II trial of proton versus photon (x-ray) radiotherapy for locally advanced non-small cell lung cancer.RTOG 1308, randomized phase III trial of proton versus photon (x-ray) radiotherapy for locally advanced non-small cell lung cancer. Now filled, awaiting results!Lin et al., randomized phase IIB trial of proton versus photon (x-ray) radiotherapy for locally advanced esophageal cancer.NRG GI-006, randomized phase III trial of proton versus photon (x-ray) radiotherapy for locally advanced esophageal cancer, enrolling now!Oncology Unscripted is a Photon Media production. Intro and Outro music by Emmy-award winning artist Lucas Cantor Santiago.Additional content from Katie Coleman can be found at her website, https://www.katiekickscancer.com/. This show and our opinions are meant for general informational purposes and are not medical advice. We encourage you to reach out to your doctors to discuss your individual case. 

Dennis Varghese BSRT(T) joins us to share insight into the development of a high quality team in a new Proton Therapy Center, and we discuss Dennis' leadership tips for those in and around the field of Radiation Oncology

Brain surgery couldn't remove all of Lisa Webb's tumors, so she became the very first adult patient to get proton therapy at The University of Kansas Cancer Center. Find out how she's doing now that she has completed her treatment.

While proton therapy is still uncommon in the US, it's quickly gaining traction as a more precise cancer treatment with a lot fewer side effects for our patients.  But is it worth knowing about if you don't have a proton therapy center in your area?Short answer: ABSOLUTELY!Dive into the world of proton therapy with me as I interview Dr. Andrew Lee of Texas Center for Proton Therapy.  We covered everything you need to know about proton therapy, including how proton therapy compares to more conventional XRT, side effects of proton therapy, & just what the research shows us about proton therapy's benefits.Listen now!Download your FREE Quick Guide to Treating Patients with Cancer.Because it's not if, it's when you'll treat a person with cancer.Follow TheOncoPT on Instagram:https://Instagram.com/TheOncoPT This episode is brought to you by our brand new Cancer Basics Course. With the Cancer Basics Course, you'll get our exact blueprint to start treating people with cancer confidently & competently. No more ramshackling together your oncology knowledge.Start treating your patients with cancer confidently & competently TODAY. Register now at TheOncoPT.com/cancerbasicscourseFollow TheOncoPT on Instagram.Follow TheOncoPT on TikTok.Follow TheOncoPT on Twitter.

We are profiling the 100th proton patient at The University of Kansas Cancer Center – a woman who had a complex tumor that was no problem for the new technology.

In this episode, host Shikha Jain, MD, speaks with Isabelle Choi, MD, about the use of proton therapy in radiation oncology, improving accessibility to radiation technology and more. •    Welcome to another exciting episode of Oncology Overdrive :14 •    About Choi :27 •    The interview 2:00 •    Can you tell us about your journey to become a radiation oncologist? 2:18 •    What is proton therapy, and how does it work?  4:57 •    What types of cancer can receive proton therapy? 7:35 •    What do you look for to decide if somebody should or should not get proton therapy? 10:41 •    What are ways to improve the overall outcomes in toxicity during cancer care that you have found in your research in proton therapy? 13:49 •    Do you feel like there is a challenge in the equity space? How do we address that in this field that is needed in many populations, but is often not able to be delivered due to lack of resources?  17:51  •    Have you had challenges with patients not understanding what radiation oncology is? … How do you address that concern or mistrust that patients may bring? 23:46 •    Jain and Choi on multidisciplinary communication when it comes to supporting patients 27:33 •    Jain and Choi on the challenges of making extra time for patient communication in the setup of the current health care system and physician burnout 31:22  •    If someone could only listen to the last minute of this episode, what would you want them to take away? 36:15 •    How to contact Choi 37:27 •    Thanks for listening 38:00 Isabelle Choi, MD, is the director of research and clinical director at the New York Proton Center. She is a radiation oncology attending in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Dr. Choi can be reached at www.nyproton.com or on the Memorial Sloan Kettering website. Disclosures: Choi and Jain report no relevant financial disclosures.

The new machine has never been used on people and "represents a paradigm shift in the field," according to the institute.

Tumour hypoxia occurs when cancer cells lack oxygen, and is associated with decreased effectiveness of radiotherapy treatments. One way to counteract hypoxia is to increase the dose of radiation we use to kill cancer cells, a technique called dose escalation.  However, many side effects have been reported due to surrounding organs being damaged by off-target radiation.Researchers at the Paul Scherrer Institute in Switzerland, led by Dr Giovanni Fattori, have been investigating the clinical potential of hypoxia-guided radiotherapy with protons in advanced-stage lung cancer treatments.Read the original paper: https://doi.org/10.1186/s13014-021-01914-2

Community DC Host Dennis Glasgow has a chance to visit with Dr Phew Tran whos a physician/scientist and is the Vice Chair of Research, Professor of Radiation Oncology at the University of Maryland School of Medicine to talk about treating certain types of cancers with Proton Therapy...

Welcome, everyone, to Campus PEPTalk Global Edition. In this episode we are joined by Dr. Rakesh Jalali, Medical Director of the first proton therapy center in India - Apollo Proton Cancer Centre - who will share some insights from his center's 4 years' experience in proton therapy.   The views expressed in this podcast are those of the interviewees. By listening to this, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating.  Consult your own physician for any medical issues that you may be having.  This entire disclaimer also applies to any guests or contributors to the podcast.  Under no circumstances shall Ion Beam Applications SA (IBA), any guests or contributors to the podcast, or any employees, associates, or affiliates of IBA be responsible for damages arising from use of the podcast.

Learn about one of the first proton therapy patients at the University of Kansas Cancer Center. How did it work on non-cancerous tumors threatening his brain and spine? Guests include Dr. Raed Al-Rajabi and Dr. Ronny Rotondo.

Advanced Oncotherapy PLC's (AIM:AVO) chief executive Nicolas Serandour tells Proactive's Thomas Warner that it was a huge milestone for the business to get its proton beam therapy system running at full capacity. AVO's LIGHT system, which is significantly smaller than the existing standard-of-care technology, recently produced a proton beam at 230 megaelectron volts (MeV) at its assembly site in Daresbury, Cheshire, something he says was a key step in its development. The company now has all the ammunition it needs to meet its objective to "democratise proton therapy" for the treatment of cancer tumours, he adds, with the next stage being first patients at Daresbury 'in the second half of next year'. #ProactiveInvestors #AdvancedOncotherapy #LIGHT #AIM

Nearly a quarter of a million men will find out they have prostate cancer by the end of the year. But could tissue sparing proton therapy treatment a good choice for these patients? We hear from two patients a decade out from their treatment and a local man just beginning his.

Welcome, everyone, to Campus PEPTalk Global Edition. In this episode we are joined by Dr. Gustavo Santa Cruz and Dr. Pablo Menendez from Argentina who will share their story of how they came to be the first country in Latin America with Proton Therapy. We are also joined by a special guest and co-host Dr. Ali Onuralp from IBA who will be leading this episode in Spanish. The views expressed in this podcast are those of the interviewees. By listening to this, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating.  Consult your own physician for any medical issues that you may be having.  This entire disclaimer also applies to any guests or contributors to the podcast.  Under no circumstances shall Ion Beam Applications SA (IBA), any guests or contributors to the podcast, or any employees, associates, or affiliates of IBA be responsible for damages arising from use of the podcast.

Dr. Gayar (Medical Director for the McLaren Proton Therapy Center) talks about proton therapy and its benefits in cancer care. Dr. Gayar explains what proton beam therapy is, the forms of cancer that can be treated with this therapy, and who is a good candidate for it.

This episode marks our first episode of Campus PEPTalk Global Edition, our mini-series of PEPTalk episodes dedicated to amplifying the voices of global leaders in the field of Proton Therapy.  We are joined by Professor Roberto Orecchia, Scientific Director of European Institute of Oncology Milan to discuss randomized control trials, or “RCTs”, in proton therapy. The views expressed in this podcast are those of the interviewees. By listening to this, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating.  Consult your own physician for any medical issues that you may be having.  This entire disclaimer also applies to any guests or contributors to the podcast.  Under no circumstances shall Ion Beam Applications SA (IBA), any guests or contributors to the podcast, or any employees, associates, or affiliates of IBA be responsible for damages arising from use of the podcast.

July 15, 2022 RJ podcast: Who Rescues Who? Lung Cancer Hypofractionation and Proton Therapy. The latest podcast by Sue Yom, MD, Editor-in-Chief of the International Journal of Radiation Oncology, Biology, Physics addresses the status of hypofractionation in radiation therapy for locoregonally advanced lung cancer. Articles discussed include Hoppe et al.'s article "Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial", Contreras et al.'s article "Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non Small Cell Lung Cancer", and Brownstein and Salama's editorial, "Moderately Hypofractionated Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: A New Way Forward for Dose Escalation?" which is available in the July 15, 2022 issue.

May marks Brain tumor awareness month. In this episode we are joined by Dr. Helen Shih, radiation oncologist and medical director at Massachusetts General Hospital who specializes in brain cancers. The views expressed in this podcast are those of the interviewees. By listening to this, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating.  Consult your own physician for any medical issues that you may be having.  This entire disclaimer also applies to any guests or contributors to the podcast.  Under no circumstances shall Ion Beam Applications SA (IBA), any guests or contributors to the podcast, or any employees, associates, or affiliates of IBA be responsible for damages arising from use of the podcast.

In this episode, we are joined by Dr. Brian Chon, medical director at the ProCure Proton Therapy Center to discuss their unique journey into PT and how his facility has used strong partnerships to grow and evolve over the past 10 years. The views expressed in this podcast are those of the interviewees. By listening to this, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating.  Consult your own physician for any medical issues that you may be having.  This entire disclaimer also applies to any guests or contributors to the podcast.  Under no circumstances shall Ion Beam Applications SA (IBA), any guests or contributors to the podcast, or any employees, associates, or affiliates of IBA be responsible for damages arising from use of the podcast.

Proton therapy is an effective technique for fighting cancer. In order to optimise treatment, it is clear that each patient must be carefully assessed each time and radiation plans must be adapted based on the results. The daily adaptive proton therapy workflow proposed by the Paul Scherrer Institute is an excellent start on the path to achieving this, and there are many more opportunities to improve efficiency and accuracy for treatment. Read the original article: https://doi.org/10.1088/1361-6560/ac2b84

Today we look back at the past 20+ years of proton therapy treatment at Massachusetts General Hospital, the first hospital in North America to have an IBA Proton therapy system. We'll be speaking with Dr. Anthony Zietman, the Interim Chief of Radiation Oncology at MGH to better understand how the field has changed over the years.The views expressed in this podcast are those of the interviewees. By listening to this, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating.  Consult your own physician for any medical issues that you may be having.  This entire disclaimer also applies to any guests or contributors to the podcast.  Under no circumstances shall Ion Beam Applications SA (IBA), any guests or contributors to the podcast, or any employees, associates, or affiliates of IBA be responsible for damages arising from use of the podcast.

Trevor Cooke is one of the State's most highly regarded property and finance leaders and has an outstanding track record in funds management globally, and a wealth of experience in the property and health sector. In his role as CEO, Trevor provides Commercial & General with a competitive advantage as the company continues to expand its national footprint.  He is an experienced operator with a diverse skill set which enables C&G to deliver a truly unique and complete business solution across funding and investment models, design and development, program and project management, feasibility analysis, building, marketing and sales. Trevor's portfolio of projects includes Calvary Adelaide Hospital, 88'O'Connel Street and the Australian Bragg Centre for Proton Therapy & Research.   Further to this Trevor sits across multiple boards for Junction Australia, Asia Pacific Real Estate Association,  Committee for Adelaide  and is division councillor for property council of Australia.  In this episode:Listen to Trevor as he spoke in detail about his journey which started where he was born in Canada, then all around the world to where we find him today as the CEO of Commercial & General.  Daniel and Trevor also deep dived into:  His personal life, how he manages his time having so many roles The importance of the values and how it drives behaviour  His beliefs in 'Open doors Culture' and 'Meritocracy Culture' The culture of Commercial & General that allows him to balance business and family time Characteristics to be a great CEO What it means to lead with integrity  Commercial & General history, journey, purpose and projectsTrevor's thoughts on South Australia,  attracting investors and capital to AdelaideHis expectations coming out from the omicron situation How the pandemic has been handled politically Mental health, meditation and mind mapping  Books and Podcast mentioned in this episode:Rapid Transformation - An Outcomes-Baed Approach to Drive Results - By Ali DavachiThe Moral Landscape - By Sam HarrisDoom - The Politics of Catastrophe - By Niall FergusonThe Ascent Of Money - Financial History Of The World - By Niall FergusonHitch-22 - A Memoir - By Christopher HitchensMaking Sense Podcast Between the Lines PodcastSaturday ExtraWhere to find Trevor CookeLinkedInJoin the conversation on Synergy IQ LinkedIn, Facebook and Instagram (@synergyiq) and please support other leaders by liking, subscribing and sharing this podcast. Access SynergyIQ Website to get to know more about us. Say hello to our host Daniel Franco on LinkedIn.

Today we discuss the role of proton therapy for prostate cancer. It has been referred to as "experimental", but is showing to be increasingly advantageous and we'll hear why from Dr. Andrew Lee, Medical Director of Texas Center for Proton Therapy. The views expressed in this podcast are those of the interviewees. By listening to this, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating.  Consult your own physician for any medical issues that you may be having.  This entire disclaimer also applies to any guests or contributors to the podcast.  Under no circumstances shall Ion Beam Applications SA (IBA), any guests or contributors to the podcast, or any employees, associates, or affiliates of IBA be responsible for damages arising from use of the podcast.

In this episode we are joined by special guest Heather Oakley from University of Florida Health Proton Therapy Institute, who just celebrated their 15 year anniversary treating patients with protons! Heather is the director of social services and will give us some insight and understanding into what it's like to be a patient or family member going through proton therapy treatment. The views expressed in this podcast are those of the interviewees. By listening to this, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating.  Consult your own physician for any medical issues that you may be having.  This entire disclaimer also applies to any guests or contributors to the podcast.  Under no circumstances shall Ion Beam Applications SA (IBA), any guests or contributors to the podcast, or any employees, associates, or affiliates of IBA be responsible for damages arising from use of the podcast.

September marks Childhood Cancer Awareness Month, so this episode will focus on pediatric cancer treatment and the many ways proton therapy can benefit children. I'm also delighted to share with you that our guest this episode, Dr. Torunn Yock, joins us from Massachusetts General Hospital, the first center in North America to have an IBA system and they are celebrating their 20 year anniversary with proton this year! The views expressed in this podcast are those of the interviewees. By listening to this, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating.  Consult your own physician for any medical issues that you may be having.  This entire disclaimer also applies to any guests or contributors to the podcast.  Under no circumstances shall Ion Beam Applications SA (IBA), any guests or contributors to the podcast, or any employees, associates, or affiliates of IBA be responsible for damages arising from use of the podcast.

President Joe Biden recently spoke very enthusiastically about the importance of cancer research. In March, he described Proton Therapy, specifically, as being “a source of hope,” and encouraged a continued “focus on proton therapy.” Despite this, Proton therapy is currently under pressure by something called RO-APM. In this episode, we interview Jennifer Maggiore of NAPT and break down what RO-APM is, how it's affecting PT, and what you can do to help. The views expressed in this podcast are those of the interviewees. By listening to this, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating.  Consult your own physician for any medical issues that you may be having.  This entire disclaimer also applies to any guests or contributors to the podcast.  Under no circumstances shall Ion Beam Applications SA (IBA), any guests or contributors to the podcast, or any employees, associates, or affiliates of IBA be responsible for damages arising from use of the podcast.

In this episode, we interview David Raubach from Oklahoma Proton Center and discuss the challenges, the lessons learned, and also the successes that have lead him and his team to where they are today – which is running a highly successful proton center that keeps patient storytelling at the heart of what they do. The views expressed in this podcast are those of the interviewees. By listening to this, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating.  Consult your own physician for any medical issues that you may be having.  This entire disclaimer also applies to any guests or contributors to the podcast.  Under no circumstances shall Ion Beam Applications SA (IBA), any guests or contributors to the podcast, or any employees, associates, or affiliates of IBA be responsible for damages arising from use of the podcast.

In this episode, we interview Dr. Lane Rosen from Willis Knighton Health System and discuss why the field of cancer therapy should take notice of proton therapy and how it can play a valuable role in your radiotherapy department.The views expressed in this podcast are those of the interviewees. By listening to this, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating.  Consult your own physician for any medical issues that you may be having.  This entire disclaimer also applies to any guests or contributors to the podcast.  Under no circumstances shall Ion Beam Applications SA (IBA), any guests or contributors to the podcast, or any employees, associates, or affiliates of IBA be responsible for damages arising from use of the podcast or blog.

On this C-Sessions with Randall Broad an interview with Dr. Jing Zeng, an Associate Professor in the Department of Radiation Oncology at the University of Washington School of Medicine. There are congratulations in order to Dr. Jing Zeng, who officially became the SCCA Proton Therapy Center's Medical Director on October 16, after serving as Associate Medical Director since 2019. Like many, Dr. Zeng was drawn to health care because she wanted to help people. She studied at Duke University and completed her residency at Johns Hopkins Hospital focusing on radiation oncology. Although treating cancer is extremely challenging, Dr. Zeng knew it was her calling. "It's a privilege that my job is to help people in their time of dire need. Work doesn't feel like work when you know what you're doing is meaningful," says Dr. Zeng. As one of the first physicians to treat at the Center, Dr. Zeng initially specialized in lung cancer radiation. By 2014, she expanded her role to lead the genitourinary/prostate cancer program - at one time, treating nearly half of the Center's prostate cancer patients. --- Support this podcast: https://anchor.fm/randall-broad/support

You may have heard about proton therapy and wondered if it's an option for you during breast cancer treatment. If so, how does it differ from traditional radiation? Should you ask your doctor about it? We'll find out all the facts as our special guest, Dr. Storey of Oklahoma Proton Center shares with hosts Sarah and Jane.

Radiation treatment for cancer is very hard on patients. But now, doctors are using a powerful technological treatment that targets just the cancer cells while leaving the patient with minimal side effects. It's called Proton Therapy. In this heartfelt episode of Komando on Demand, Kim explores this new form of cancer treatment that's taking the medical world by storm, and talks to Lee Chamblee, the Education Program Coordinator at the University of Texas MD Anderson Proton Therapy Center. Learn more about your ad choices. Visit megaphone.fm/adchoices